Depreciation of Horizon Therapeutics Public Ltd Co from 31 Dec 2010 to 30 Jun 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Horizon Therapeutics Public Ltd Co quarterly and annual Depreciation in USD history and change rate from 31 Dec 2010 to 30 Jun 2023.
  • Horizon Therapeutics Public Ltd Co Depreciation for the quarter ending 30 Jun 2023 was $6,700,000, a 9.8% increase year-over-year.
  • Horizon Therapeutics Public Ltd Co Depreciation for the twelve months ending 30 Jun 2023 was $24,800,000, a 15% increase year-over-year.
  • Horizon Therapeutics Public Ltd Co annual Depreciation for 2022 was $23,900,000, a 37% increase from 2021.
  • Horizon Therapeutics Public Ltd Co annual Depreciation for 2021 was $17,500,000, a 28% decline from 2020.
  • Horizon Therapeutics Public Ltd Co annual Depreciation for 2020 was $24,300,000, a 261% increase from 2019.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Horizon Therapeutics Public Ltd Co Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $24,800,000 $6,700,000 +$600,000 +9.8% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $24,200,000 $6,200,000 +$300,000 +5.1% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $23,900,000 $5,770,000 +$225,000 +4.1% 01 Oct 2022 31 Dec 2022 10-K 01 Mar 2023 2022 FY
Q3 2022 $23,675,000 $6,130,000 +$2,019,000 +49% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $21,656,000 $6,100,000 +$2,707,000 +80% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $18,949,000 $5,900,000 +$1,449,000 +33% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q4 2021 $17,500,000 $5,545,000 +$474,000 +9.3% 01 Oct 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $17,026,000 $4,111,000 -$1,046,000 -20% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 $18,072,000 $3,393,000 -$3,514,000 -51% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $21,586,000 $4,451,000 -$2,714,000 -38% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $24,300,000 $5,071,000 +$2,912,000 +135% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q3 2020 $21,388,000 $5,157,000 +$3,499,000 +211% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 $17,889,000 $6,907,000 +$5,464,000 +379% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021 2021 Q2
Q1 2020 $12,425,000 $7,165,000 +$5,692,000 +386% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 $6,733,000 $2,159,000 +$659,000 +44% 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q3 2019 $6,074,000 $1,658,000 +$135,000 +8.9% 01 Jul 2019 30 Sep 2019 10-Q 02 Nov 2020 2020 Q3
Q2 2019 $5,939,000 $1,443,000 -$108,000 -7% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $6,047,000 $1,473,000 -$79,000 -5.1% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q4 2018 $6,126,000 $1,500,000 -$100,000 -6.2% 01 Oct 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
Q3 2018 $6,226,000 $1,523,000 +$47,000 +3.2% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q2 2018 $6,179,000 $1,551,000 -$204,000 -12% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $6,383,000 $1,552,000 -$248,000 -14% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q4 2017 $6,631,000 $1,600,000 -$62,000 -3.7% 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
Q3 2017 $6,693,000 $1,476,000 +$276,000 +23% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $6,417,000 $1,755,000 +$655,000 +60% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 $5,762,000 $1,800,000 +$800,000 +80% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q4 2016 $4,962,000 $1,662,000 -$838,000 -34% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
Q3 2016 $5,800,000 $1,200,000 -$400,000 -25% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017 2017 Q3
Q2 2016 $6,200,000 $1,100,000 +$500,000 +83% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q2
Q1 2016 $5,700,000 $1,000,000 +$300,000 +43% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017 2017 Q1
Q4 2015 $5,400,000 $2,500,000 +$2,000,000 +400% 01 Oct 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
Q3 2015 $3,400,000 $1,600,000 +$1,200,000 +300% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016 2016 Q3
Q2 2015 $2,200,000 $600,000 +$200,000 +50% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2
Q1 2015 $2,000,000 $700,000 +$300,000 +75% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q4 2014 $1,700,000 $500,000 +$161,000 +47% 01 Oct 2014 31 Dec 2014 10-K 27 Feb 2017 2016 FY
Q3 2014 $1,539,000 $400,000 +$98,000 +32% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015 2015 Q3
Q2 2014 $1,441,000 $400,000 +$100,000 +33% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q1 2014 $1,341,000 $400,000 +$141,000 +54% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015 2015 Q1
Q4 2013 $1,200,000 $339,000 +$98,000 +41% 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
Q3 2013 $1,102,000 $302,000 +$135,000 +81% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014 2014 Q3
Q2 2013 $967,000 $300,000 +$92,000 +44% 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014 2014 Q2
Q1 2013 $875,000 $259,000 +$75,000 +41% 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014 2014 Q1
Q4 2012 $800,000 $241,000 01 Oct 2012 31 Dec 2012 10-K/A 02 Mar 2015 2014 FY
Q3 2012 $167,000 +$69,000 +70% 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2013 2013 Q3
Q2 2012 $208,000 +$107,000 +106% 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013 2013 Q2
Q1 2012 $184,000 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q3 2011 $98,000 01 Jul 2011 30 Sep 2011 10-Q 13 Nov 2012 2012 Q3
Q2 2011 $101,000 01 Apr 2011 30 Jun 2011 10-Q 10 Aug 2012 2012 Q2

Horizon Therapeutics Public Ltd Co Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $23,900,000 +$6,400,000 +37% 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2023 2022 FY
2021 $17,500,000 -$6,800,000 -28% 01 Jan 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
2020 $24,300,000 +$17,567,000 +261% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $6,733,000 +$607,000 +9.9% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $6,126,000 -$505,000 -7.6% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $6,631,000 +$1,669,000 +34% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $4,962,000 -$438,000 -8.1% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $5,400,000 +$3,700,000 +218% 01 Jan 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
2014 $1,700,000 +$500,000 +42% 01 Jan 2014 31 Dec 2014 10-K 27 Feb 2017 2016 FY
2013 $1,200,000 +$400,000 +50% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $800,000 +$354,000 +79% 01 Jan 2012 31 Dec 2012 10-K/A 02 Mar 2015 2014 FY
2011 $446,000 +$209,000 +88% 01 Jan 2011 31 Dec 2011 10-K 13 Mar 2014 2013 FY
2010 $237,000 01 Jan 2010 31 Dec 2010 10-K 18 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.